Literature DB >> 8897933

Inotropic agent EMD-53998 weakens nucleotide and phosphate binding to cross bridges in porcine myocardium.

Y Zhao1, M Kawai.   

Abstract

The effect of EMD-53998 (EMD) on elementary steps of the cross-bridge cycle in skinned porcine myocardium was studied to understand the positive inotropic mechanisms of EMD. The kinetic constants of the elementary steps were obtained by sinusoidal analysis and compared in the presence and absence of 50 microM EMD. In the presence of 50 microM EMD, the equilibrium constant of the cross-bridge detachment step decreases three times, and the equilibrium constant of the cross-bridge attachment (force generation) step increases two times. Our results further show that, in the presence of 50 microM EMD, the association constants of MgATP and MgADP decrease to one-ninth and one-third, respectively, and the association constant of phosphate decreases to one-third. These results indicate that EMD suppresses the nucleotide binding to cross bridges and increases cross-bridge resistance to phosphate accumulation in myocardium. These results predict that EMD decreases the number of detached cross bridges and increases the number of attached cross bridges. This prediction is consistent with the twofold increase of isometric tension with 50 microM EMD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897933     DOI: 10.1152/ajpheart.1996.271.4.H1394

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Elementary steps of the cross-bridge cycle in bovine myocardium with and without regulatory proteins.

Authors:  Hideaki Fujita; Daisuke Sasaki; Shin'ichi Ishiwata; Masataka Kawai
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

2.  Nonlinear myofilament regulatory processes affect frequency-dependent muscle fiber stiffness.

Authors:  K B Campbell; M V Razumova; R D Kirkpatrick; B K Slinker
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

Review 3.  What do we learn by studying the temperature effect on isometric tension and tension transients in mammalian striated muscle fibres?

Authors:  Masataka Kawai
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

4.  The effect of tropomyosin on force and elementary steps of the cross-bridge cycle in reconstituted bovine myocardium.

Authors:  Hideaki Fujita; Xiaoying Lu; Madoka Suzuki; Shin'ichi Ishiwata; Masataka Kawai
Journal:  J Physiol       Date:  2004-01-23       Impact factor: 5.182

5.  Effects of tropomyosin internal deletion Delta23Tm on isometric tension and the cross-bridge kinetics in bovine myocardium.

Authors:  Xiaoying Lu; Larry S Tobacman; Masataka Kawai
Journal:  J Physiol       Date:  2003-09-18       Impact factor: 5.182

6.  Role of the N-terminal negative charges of actin in force generation and cross-bridge kinetics in reconstituted bovine cardiac muscle fibres.

Authors:  Xiaoying Lu; Mary K Bryant; Keith E Bryan; Peter A Rubenstein; Masataka Kawai
Journal:  J Physiol       Date:  2005-01-13       Impact factor: 5.182

Review 7.  Use of thin filament reconstituted muscle fibres to probe the mechanism of force generation.

Authors:  Masataka Kawai; Shin'ichi Ishiwata
Journal:  J Muscle Res Cell Motil       Date:  2006-08-15       Impact factor: 2.698

Review 8.  Force transients and minimum cross-bridge models in muscular contraction.

Authors:  Masataka Kawai; Herbert R Halvorson
Journal:  J Muscle Res Cell Motil       Date:  2008-04-19       Impact factor: 2.698

9.  Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.

Authors:  Priya Muthu; Li Wang; Chen-Ching Yuan; Katarzyna Kazmierczak; Wenrui Huang; Olga M Hernandez; Masataka Kawai; Thomas C Irving; Danuta Szczesna-Cordary
Journal:  FASEB J       Date:  2011-09-01       Impact factor: 5.191

10.  Elementary steps of the cross-bridge cycle in fast-twitch fiber types from rabbit skeletal muscles.

Authors:  Stefan Galler; Brant Gang Wang; Masataka Kawai
Journal:  Biophys J       Date:  2005-09-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.